Gastroesophageal Reflux Disease Therapeutics Market Key Players Analysis - AstraZeneca; Eisai Co. Ltd.; GSK plc.; Takeda Pharmaceutical Company Limited.; Ironwood Pharmaceuticals, Inc.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-kinetic agents)- Market Outlook And Industry Analysis 2031"

The global Gastroesophageal Reflux Disease Therapeutics market is estimated to reach over 6.08 billion by the year 2031, exhibiting a CAGR of 1.81% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1705

The gastroesophageal reflux disease (GERD) market is projected to experience significant growth during the forecast period, driven by the increasing prevalence of gastric reflux disorders, evolving lifestyle habits, and heightened awareness of GERD among the population. According to a July 2022 article from the National Library of Medicine titled Gastroesophageal Reflux Disease, GERD is one of the most prevalent chronic gastrointestinal conditions, affecting approximately 20% of individuals in Western societies. Characterized by the backflow of stomach contents into the esophagus, the high incidence of this condition among the target population is expected to contribute to greater awareness, diagnosis, and subsequent treatment, thereby fostering market expansion.

In addition, strategic initiatives by market participants-such as new product launches, mergers and acquisitions, and targeted investments-are anticipated to further accelerate market growth. For example, in October 2021, Medical City Frisco launched a dedicated Heartburn & Reflux Center, the first of its kind in Collin and Dallas counties. The center provides advanced minimally invasive robotic and laparoscopic treatment options for GERD and esophageal disorders, including transoral incisionless fundoplication (TIF). Such developments are expected to positively influence the market trajectory in the coming years.

List of Prominent Players in the Gastroesophageal Reflux Disease Therapeutics Market:
• AstraZeneca;
• Aurobindo Pharma Limited
• Cadila Pharmaceuticals Limited
• Camber Pharmaceuticals Inc.
• CHEPLAPHARM Arzneimittel GmbH
• Daewoong Pharmaceutical Co., Ltd
• Eisai Co. Ltd.
• EndoStim, Inc.
• GlaxoSmithKline PLC
• Ironwood Pharmaceuticals, Inc.;
• Jeil Pharmaceutical Co., Ltd.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Phathom Pharmaceuticals Inc.
• Reckitt Benckiser Group PLC
• Sebela Pharmaceuticals
• SFJ Pharmaceuticals Group
• SRS Life Sciences Pte. Ltd.
• Sun Pharmaceutical Industries Limited
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceuticals Industries Limited

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics:
Drivers:
Transoral incisionless fundoplication (TIF) is a key treatment for gastroesophageal reflux disease (GERD) that offers advantages such as shorter treatment duration, reduced pain, and faster recovery compared to traditional laparoscopic surgery. This procedure utilizes a specialized TIF device to create a pathway for an endoscope, which is a flexible tube used for imaging. The procedure enables the physician to secure or replace the valve, which acts as a natural barrier against reflux, using preloaded tweezers and fasteners. Clinical trials are underway to assess the efficacy of endoscopic treatments for GERD. To enhance the anti-reflux barrier, stitches are placed in the stomach using an endoscopic sewing machine. These innovations are expected to drive significant market growth during the forecast period.

Challenges:
Despite the favorable market conditions, there are several challenges, including patient mortality and an underdeveloped treatment pipeline. The market also faces intense competition due to the availability of numerous existing treatments for GERD symptoms, which contributes to a highly competitive landscape.

Regional Trends:
North America is projected to dominate the market and maintain its leading position throughout the forecast period. The United States, in particular, is driving this growth due to factors such as increasing healthcare spending, advancements in research and technology, and the rising prevalence of GERD. Furthermore, the aging population in the United States is a major contributor to the growing demand for GERD treatments.

Laparoscopic Nissen fundoplication, a surgical procedure used to treat GERD, is becoming more common as the incidence of GERD continues to rise, particularly in Western nations, including the United States. According to a July 2022 article on Nissen Fundoplication from the National Library of Medicine, GERD affects 18.1% to 27.8% of the U.S. population, making it one of the most prevalent conditions in the country. Given the high prevalence of the disease, the demand for advanced and effective medications and treatments is expected to grow, further propelling the market's expansion in the U.S.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1705

Recent Developments:
• In June 2022, The Food and Drug Administration (FDA) permitted Zydus Lifesciences to market Famotidine tablets in strengths of 20mg and 40mg. Famotidine is a histamine H2 receptor blocker that functions by reducing stomach acid. The medication also prevents and treats heartburn and other acid indigestion symptoms.

Segmentation of Gastroesophageal Reflux Disease Therapeutics Market-
By Drug Type-
• Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)
• Pro-kinetic agents
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/gastroesophageal-reflux-disease-therapeutics-market/1705

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.